• What is antiviral medication?

    Antiviral medications may help you recover from COVID-19 faster, or prevent you from becoming seriously ill. The medication can boost the immune system, helping it fight off COVID-19 infection. Vaccinations remain the best way to protect a person from COVID, and are a preventative measure to reduce severity of illness and risk of hospitalization or, even, death. Antivirals are prescribed after a person has tested positive for COVID-19 and within 5 days of symptom onset.



  • What is monoclonal antibody therapy?

    Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies that can restore, enhance or mimic the immune system. Monoclonal antibodies are designed to block viruses by not allowing them to attach and enter human cells, thus neutralizing the virus. Monoclonal antibodies may be effective for the treatment of COVID-19 patients who are at high risk for progressing to severe COVID-19 and/or hospitalization.

    Monoclonal antibody treatment is for people who have tested positive for COVID-19 and have mild to moderate symptoms. These treatments are allowed by the U.S. Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) while clinical studies continue to look at their usefulness and safety. Recently the FDA approved the use of monoclonal antibodies to treat certain high-risk adult and pediatric patients who have been exposed to COVID-19.  This treatment method is known as post-exposure prophylaxis, or PEP. 

    When administered to non-hospitalized patients as soon as possible after testing positive for COVID-19 and within 7 days of symptom onset, monoclonal antibody therapy may reduce symptoms and risk of hospitalizations and emergency room visits associated with COVID-19. 

    The use of sotrovimab, REGEN-COV and bamlanivimab + etesevimab have had their emergency use authorization paused, as they did not demonstrate effectiveness against the BA.2 sub-variant.

    Is monoclonal antibody therapy right for me?




    Bamlanivimab + Etesevimab